The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patientsResearch article Published on 2022-09-012022-10-05 Journal: Blood cells, molecules & diseases [Category] 바이오마커, 진단, [키워드] analyzed association Biomarker CLIA Coagulopathies Coagulopathy Concentration correlated correlation diagnostic value disease severity ELISA evaluate expression expression level finding flow cytometry four groups IL-6 IL-6 levels immunothrombosis infected patient Infection marker MPO myeloperoxidase NETosis NETs Neutrophil extracellular trap neutrophilic outcomes Patient plasma Prognostic factor reduced Result risk serum Serum level Surface myeloperoxidase triggering Variation were measured [DOI] 10.1016/j.bcmd.2022.102676 [Article Type] Research article
Factors affecting the serologic response to SARS-CoV-2 vaccination in patients with solid tumors: A prospective study고형암 환자에서 SARS-CoV-2 백신접종에 대한 혈청학적 반응에 영향을 미치는 요인: 전향적 연구Observational Study Published on 2022-09-012022-09-12 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 임상, 진단, [키워드] addition affecting analyzed Anti-SARS-CoV-2 S antibody antibody level Antibody test baseline blood sample BNT162b2 Cancer Chemotherapy CLIA clinical feature clinical study collected CoronaVac CoronaVac. COVID-19 demographic determine diagnoses dose enzyme evaluate Factor first dose IgG antibody IgG level immunoassay in both groups inactivated men mRNA vaccine of BNT162b2 oncology Patient Patients with cancer positive preventive measure proportion Prospective Study Quantitative RBD receiving Receptor binding domain SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 PCR SARS-CoV-2 vaccination SARS-CoV-2 vaccine SARS-CoV-2 vaccines second dose Serologic response Sex significantly significantly higher single-center study solid tumor solid tumors vaccination Vaccine Vaccines virus spike protein was determined were excluded were measured [DOI] 10.1016/j.jiac.2022.05.021 PMC 바로가기 [Article Type] Observational Study
Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational studyObservational Study Published on 2022-09-012022-10-04 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] age antibody kinetics approval binding antibody booster CLIA CoronaVac Course COVID-19 COVID-19 vaccines ELISA enzyme-linked immunosorbent evaluate Factors HCW HCWs healthcare worker immunoassay inactivated NAb negative correlation neutralizing antibody optic density Participants Pearson correlation propensity score analysis prospective observational study response SARS-CoV-2 SARS-CoV-2 antibody significant decrease significantly single center the antibody response the vaccine titer Turkey Vaccine Vero Cell was determined was performed were used [DOI] 10.1016/j.ijid.2022.05.007 PMC 바로가기 [Article Type] Observational Study
SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection studyArticle Published on 2022-08-172022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] acute infections addition Antibody titer block CLIA clinician Cohort comparability comparable convalescent COVID-19 disease COVID-19 patient Cutoff diagnostics ELISA FIVE help immune immune response increasingly individual immune response Infection information Laboratory long-COVID long-term assay comparison Mild mild progression COVID-19 mild SARS-CoV-2 infection Molecular diagnosis neutralization Neutralizing neutralizing potential Occurrence offered pandemic participant Participants Patient Post-infection progression quantification quantification immune response. Rapid SARS-CoV-2 SARS-CoV-2 antibody serological serological test specific antigen Support Symptom symptomatic vaccination Vaccine WHO [DOI] 10.3389/fimmu.2022.915338 PMC 바로가기
Commercialized kits to assess T-cell responses against SARS-CoV-2 S peptides. A pilot study in health care workersSARS-CoV-2 S 펩타이드에 대한 T 세포 반응을 평가하기 위한 상용화된 키트. 의료 종사자를 대상으로 한 파일럿 연구Article Published on 2022-08-122022-09-11 Journal: Medicina clínica [Category] SARS, 진단, 치료기술, [키워드] antibody Antibody test antibody tests Automation BNT162b2-mRNA-COVID-19-vaccine Cell mediated immunity CLIA complement Concordance correlation COVID-19 detect dose ELISA English Ensayos de liberación Interferon-gamma feasibility first vaccination group groups HCW Health care worker IFNγ immune response Immunosuppressed individual Infection Inmunidad Mediada por Células interferon Interferon-gamma-release-assays mRNA natural infection number of sample number of samples peptides pilot study positive Quantitative ranged risk S-protein SARS-CoV-2 SARS-CoV-2 N SARS-CoV-2 S SARS-CoV-2 vaccines Sensitivity and specificity Spanish susceptible T-cell Response T-cell responses vaccine dose Vacuna BNT162b2-mRNA-COVID-19. [DOI] 10.1016/j.medcli.2021.09.013 PMC 바로가기 [Article Type] Article
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 SeverityCOVID-19 중증도 결정을 위한 혈청 SARS-CoV-2 항원Article Published on 2022-07-282022-09-11 Journal: Viruses [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Antigen antigenic Antigenic assay Chemiluminescent assay CLIA COVID-19 COVID-19 diagnosis Determination diagnostic disease severity evaluate false-negative false-negative results followed by help intensive care Kinetics likelihood ratio marker N antigen nasopharyngeal non-severe patient non-severe patients onset of symptoms Patient performed polymerase chain reaction polymerase chain reactions positive Prognosis prognosis test. progression provided reverse transcriptase risk RT-PCR RT-PCRs SARS-CoV-2 SARS-COV-2 infection sensitive serum severe and non-severe patients severe COVID-19 severe patients severity Simoa swabs the WHO threshold transcriptase Viremia was determined were measured WHO Clinical Progression Scale [DOI] 10.3390/v14081653 PMC 바로가기 [Article Type] Article
Technical performance of a lateral flow immunoassay for detection of anti-SARS-CoV-2 IgG in the outpatient follow-up of non-severe cases and at different times after vaccination: comparison with enzyme and chemiluminescent immunoassays중증이 아닌 환자의 외래 추적 관찰 및 백신 접종 후 다양한 시점에서 항-SARS-CoV-2 IgG 검출을 위한 측면 유동 면역분석의 기술적 성능: 효소 및 화학발광 면역분석과의 비교Article Published on 2022-07-132022-09-12 Journal: Revista do Instituto de Medicina Tropical de São [Category] MERS, 진단, [키워드] acute phase Analysis analyzed anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibody antibody production Blood booster dose chemiluminescent immunoassay children chose CLIA collected composed Coronavirus infections COVID-19 decrease diagnosed donors Efficiency eight enzyme expected Finger prick Follow-up healthcare healthy immunoassay immunochromatographic assay Infection lateral flow lateral flow immunoassay LFIA likelihood ratio Non-severe case NPV operator participant Pediatric patient performed positive PPV produced RT-PCR sensitivity serological Serological assay serum sample serum samples Seven specificity study group tested the antibody the vaccine three group true negative vaccination Variation volunteers Whole blood [DOI] 10.1590/S1678-9946202264049 PMC 바로가기 [Article Type] Article
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study임상 실습에서 SARS-CoV-2 항체에 대한 혈청 검사: 비교 진단 정확도 연구Article Published on 2022-07-012022-09-11 Journal: Allergy [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법, [키워드] Accuracy acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analytical techniques anti-RBD anti-RBD ELISA Anti-S1 antibody chemiluminescence immunoassay CLIA Clinical practice clinical settings conducted coronavirus coronavirus disease COVID-19 COVID-19 diagnostic testing [Supplementary Concept] defined detect determine diagnostic Diagnostic accuracy diagnostic testing domain electrochemiluminescence immunoassay ELISA enzyme enzyme-linked immunosorbent assays epitope Epitopes health-care host immunity identify IgG immunoassay Infection Infections/*epidemiology/transmission*Disease Outbreaks Infectious disease Infectious diseases Inpatient lateral flow immunoassay likelihood live SARS-CoV-2 measure Nasopharyngeal swab neutralization activity neutralization assays Neutralizing antibodies neutralizing antibody nucleocapsid Patient PCR test performed positive powerful tool Protein RBD Re-infection Real-time PCR Receptor-binding domain respiratory S1/S2 S2 domain SARS-CoV-2 SARS-CoV-2 [Supplementary Concept] SARS-CoV-2 antibodies SARS-CoV-2 antibody sensitivity serological serological test Serological testing Serological tests severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 [Supplementary Concept] specificity Spike protein subgroup of patient subgroups subtype university [DOI] 10.1111/all.15206 PMC 바로가기 [Article Type] Article
Investigation of Antibody Levels During Three Doses of Sinopharm/BBIBP Vaccine InoculationSinopharm/BBIBP 백신 접종 3회 동안 항체 수준 조사Article Published on 2022-06-222022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Analysis antibody antibody kinetics antibody levels antibody persistence booster booster dose booster injection chemiluminescent immunoassay CLIA conventional virus neutralization test coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus-2 correlation Course COVID-19 COVID-19 vaccination CPE Critical cut-off Cytopathic effect detect dose healthcare worker Healthcare workers IgA level IgA levels IgG IgG antibodies IgG antibody IgM Immunity implementation inactivated injection inoculated inoculation investigation Level neutralization test Neutralizing antibodies neutralizing antibody peaked RBD receiver operating characteristic receptor remained respiratory ROC SARS-CoV-2 sensitivity Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 Sinopharm specific antibodies specificity vaccination Vaccine variety virus neutralization test VNT [DOI] 10.3389/fimmu.2022.913732 PMC 바로가기 [Article Type] Article
Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities의료 종사자에서 SARS-CoV-2 항체의 혈청 유병률: 콜롬비아 10개 도시의 다기관 단면 연구Multicenter Study Published on 2022-06-012022-09-12 Journal: Occupational and environmental medicine [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abbott antibody association automated Bayesian CLIA COVID-19 cross-sectional Cross-sectional studies determine equipment estimate evaluate general service Health Health personnel healthcare healthcare worker highest hospital IgG immunoassay increased risk Infection multicentre multivariate model Nurse occupational health Prevalence Protective public health reported Risk factors risk of infection SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2-infected patients Seroprevalence shown significant difference Sociodemographic the SARS-CoV-2 variable was determined was used [DOI] 10.1136/oemed-2021-107487 PMC 바로가기 [Article Type] Multicenter Study